HLA-DQB1 rs33980016: Peanut Allergy Susceptibility Marker
The rs33980016 variant is an intronic insertion/deletion polymorphism located within the HLA-DQB1 gene on chromosome 6. Genetic studies associate this variant with susceptibility to peanut allergy and regional differences in DNA methylation within the human leukocyte antigen (HLA) class II locus. Carrying risk-associated alleles alters relative statistical risk across populations but does not determine whether an individual will develop an allergy.
What each genotype means
Moderately increased risk
You carry one insertion (G) allele and one deletion allele at this HLA-DQB1 locus. Studies have statistically linked the insertion allele to an increased susceptibility to peanut allergy, potentially mediated by changes in regional DNA methylation and antigen presentation. Carrying this variant does not mean you have or will develop a food allergy, but reflects a moderately higher statistical likelihood compared to non-carriers.
Present in roughly 25% to 35% of individuals of European ancestry.
Elevated risk profile
You carry two copies of the insertion (G) allele for this HLA-DQB1 variant. In population association studies, homozygous carriage of this allele is correlated with higher statistical odds of developing peanut allergy and altered HLA-DQB1 methylation patterns. This result reflects genetic predisposition rather than a clinical diagnosis, and actual allergic status depends on clinical testing and other factors.
Carried by approximately 2% to 6% of individuals of European descent; frequencies vary across other global ancestries.
Genomic Context and the rs33980016 Variant
The rs33980016 polymorphism is an intronic insertion/deletion variant located within the HLA-DQB1 gene on the short arm of chromosome 6 (6p21.32). This chromosomal region houses the major histocompatibility complex (MHC), one of the most polymorphic and genetically dense regions of the human genome. Because rs33980016 resides in an intron—a non-coding intervening sequence—it does not directly alter the amino acid sequence of the HLA-DQ beta chain protein. Instead, variants in this region often function by tagging specific ancestral HLA haplotypes or by modulating nearby regulatory elements. Emerging research suggests that variants in this locus can influence local epigenetic marks, including DNA methylation levels across neighboring HLA class II genes, which may in turn alter how immune presentation genes are expressed and regulated during immune responses.
The Biological Role of HLA-DQB1
The HLA-DQB1 gene encodes the beta chain of the human leukocyte antigen DQ (HLA-DQ) heterodimer, an MHC class II cell-surface receptor. Expressed primarily on professional antigen-presenting cells such as dendritic cells, B cells, and macrophages, HLA-DQ heterodimers bind peptide fragments derived from extracellular proteins and display them to CD4-positive T-helper cells. This molecular presentation is fundamental to adaptive immunity, helping the immune system distinguish between harmless non-self proteins, pathogenic invaders, and self-peptides. Specific alleles and regulatory polymorphisms within the HLA-DQ locus have been extensively linked to immune reactivity patterns, including protective and predisposing effects in autoimmune conditions like celiac disease as well as IgE-mediated hypersensitivity disorders.
Research Evidence on Peanut Allergy Association
Peanut allergy is an IgE-mediated immune hypersensitivity that exhibits substantial familial clustering and heritability. Candidate gene studies and large genome-wide association studies (GWAS) exploring food allergy have repeatedly mapped key susceptibility signals to the HLA-DR and HLA-DQ genomic regions. Multiple investigations have shown that class II HLA variants track closely with differential antigen recognition of major peanut allergens. Research has characterized rs33980016 as an intronic marker strongly associated with peanut allergy susceptibility, showing moderate evidence strength. Studies evaluating functional mechanisms within this locus suggest that risk-associated variation correlates with altered regional DNA methylation in HLA-DQB1 and nearby genes, hinting at an epigenetic bridge connecting genomic variation to clinical allergic sensitization. However, HLA variation acts as a predisposing factor rather than a standalone cause.
Population Distribution and Linkage Disequilibrium
The frequency of the rs33980016 variant varies across global populations, reflecting the profound evolutionary pressures and balancing selection that shape the human leukocyte antigen system. In populations of European ancestry, the minor allele frequency is estimated to be approximately 0.15 to 0.25, making the alternative allele moderately common. Because the MHC region exhibits exceptionally high linkage disequilibrium, rs33980016 frequently co-segregates with specific classical HLA-DQB1 alleles and extended HLA haplotypes. The extent to which rs33980016 tags allergy risk in non-European cohorts remains an area of ongoing active study, as haplotype structures and linkage disequilibrium patterns can differ significantly across distinct ancestral groups.
Practical Implications and Clinical Perspective
Knowledge of an individual's rs33980016 genotype is educational and cannot be used to diagnose or rule out a peanut allergy. Genotypes confer relative, statistical shifts in susceptibility within examined populations, not clinical certainties. Many individuals carrying the risk-associated alleles never develop food allergies, while others without risk alleles can experience severe reactions. Clinical diagnosis of a food allergy relies exclusively on medical history, physical exams, validated diagnostic methods such as allergen-specific IgE blood tests and skin prick tests, and oral food challenges supervised by a board-certified allergist. Genetic test results must never be used to initiate food reintroduction, remove dietary items, or alter emergency allergy plans.
How common is this variant?
The minor allele frequency for rs33980016 is estimated between 0.15 and 0.25 in European ancestry populations, with frequency and haplotype patterns varying across other global ancestries.
Frequently asked questions
Can rs33980016 determine whether I have a peanut allergy?
No. The rs33980016 variant only indicates statistical susceptibility within studied populations and cannot diagnose a food allergy. Clinical allergy diagnosis requires professional medical evaluation, including symptom history, specific IgE testing, and supervised food challenges.
Does having the risk genotype guarantee my child will develop a peanut allergy?
No. Food allergies are complex traits influenced by multiple genetic loci and environmental factors, such as the timing of dietary introduction and skin barrier function. Carrying a susceptibility allele slightly changes statistical probability, but many people with risk alleles never develop an allergy.
What is the biological role of the HLA-DQB1 gene in allergies?
HLA-DQB1 provides instructions for making an MHC class II cell-surface protein that presents foreign protein fragments to immune cells. Differences in HLA-DQB1 sequence or its expression can affect how the immune system recognizes harmless food proteins like peanut antigens.
How does rs33980016 relate to DNA methylation?
Research has linked rs33980016 and related HLA variants to regional differences in DNA methylation, an epigenetic mechanism that affects gene expression. These methylation changes may influence how strongly HLA class II genes are expressed in immune cells.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs33980016?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29